Feasibility of Individualized Therapy for Recurrent Glioblastoma
Clinical trial NCT03681028 · COMPLETED
Trial details
- NCT number
- NCT03681028
- Sponsor
- Jennifer Clarke
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2023-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.